LOM
OREX

Loeb Offshore Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Loeb Offshore Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,983
Closed -$183K – 323
2013
Q3 		$183K Buy
+2,983
New +$202K 0.06% 199

Other funds holding OREX

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Loeb Offshore Management's OREX Position: Q4 2013 in Review

Loeb Offshore Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2013, closing a stake of 2,983 shares — an estimated $183K sold.

Loeb Offshore Management first reported a position in OREX in Q3 2013 and held it in 1 quarter. The position peaked at $183K in Q3 2013. 124 funds tracked by Wall St. Rank hold OREX as of Q4 2013.

  • Loeb Offshore Management reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 2,983 Orexigen Therapeutics, Inc. shares in Q4 2013, an estimated $183K.
  • Loeb Offshore Management first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Orexigen Therapeutics, Inc. position peaked at $183K in Q3 2013.
  • 124 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.